Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors

Gary K. Schwartz, Eileen O'Reilly, David Ilson, Leonard Saltz, Sunil Sharma, William Tong, Peter Maslak, Maxine Stoltz, Larry Eden, Pam Perkins, Sandra Endres, John Barazzoul, David Spriggs, David Kelsen

Research output: Contribution to journalArticlepeer-review

148 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences